Chen Junchen, Luo Cheng, Tan Dianhui, Li Yong
Department of Neurosurgery, the First Affiliated Hospital of Shantou University Medical College, Shantou, China.
Front Neurol. 2024 Jul 31;15:1417863. doi: 10.3389/fneur.2024.1417863. eCollection 2024.
Stroke, a leading cause of death and disability worldwide, is primarily ischemic and linked to hypertension. Hypertension, characterized by systemic chronic inflammation, significantly increases stroke risk. This study explores the association of novel systemic inflammatory markers (SII, PIV, SIRI) with stroke prevalence in hypertensive U.S. adults using NHANES data.
We analyzed data from hypertensive participants in the NHANES 1999-2020 survey, excluding those under 20, pregnant, or with missing data, resulting in 18,360 subjects. Systemic inflammatory markers (SII, PIV, SIRI) were calculated from blood counts. Hypertension and stroke status were determined by self-report and clinical measurements. Covariates included sociodemographic, lifestyle, and medical history factors. Weighted statistical analyses and multivariate logistic regression models were used to explore associations, with adjustments for various covariates. Ethical approval was obtained from the NCHS Ethics Review Board.
In a cohort of 18,360 hypertensive individuals (mean age 56.652 years), 7.25% had a stroke. Stroke patients were older, had lower PIR, and were more likely to be female, single, less educated, smokers, non-drinkers, physically inactive, and have diabetes and CHD. Multivariate logistic regression showed that SII was not significantly associated with stroke. However, PIV and SIRI were positively associated with stroke prevalence. Each unit increase in lnPIV increased stroke odds by 14% (OR = 1.140, = 0.0022), and lnSIRI by 20.6% (OR = 1.206, = 0.0144). RCS analyses confirmed J-shaped associations for lnPIV and lnSIRI with stroke. Stratified analyses identified gender and smoking as significant effect modifiers. Smoking was significantly associated with elevated PIV, SIRI, and SII levels, especially in current smokers.
Elevated PIV and SIRI levels significantly increase stroke prevalence in hypertensive individuals, notably among males and smokers. A predictive model with PIV, SIRI, and sociodemographic factors offers strong clinical utility.
中风是全球死亡和残疾的主要原因,主要为缺血性中风,且与高血压有关。以全身慢性炎症为特征的高血压会显著增加中风风险。本研究利用美国国家健康与营养检查调查(NHANES)数据,探讨新型全身炎症标志物(全身炎症反应指数(SII)、血小板与淋巴细胞比值(PIV)、全身免疫炎症指数(SIRI))与美国高血压成年人中风患病率之间的关联。
我们分析了1999 - 2020年NHANES调查中高血压参与者的数据,排除了20岁以下、孕妇或有缺失数据的参与者,最终得到18360名受试者。全身炎症标志物(SII、PIV、SIRI)通过血细胞计数计算得出。高血压和中风状态通过自我报告和临床测量确定。协变量包括社会人口统计学、生活方式和病史因素。采用加权统计分析和多变量逻辑回归模型来探讨关联,并对各种协变量进行了调整。研究获得了美国国家卫生统计中心伦理审查委员会的伦理批准。
在18360名高血压个体队列(平均年龄56.652岁)中,7.25%的人患有中风。中风患者年龄更大,血小板与淋巴细胞比值更低,且更可能为女性、单身、受教育程度较低、吸烟者、不饮酒者、身体活动不足,并有糖尿病和冠心病。多变量逻辑回归显示,SII与中风无显著关联。然而,PIV和SIRI与中风患病率呈正相关。lnPIV每增加一个单位,中风几率增加14%(比值比(OR)=1.140,P = 0.0022),lnSIRI每增加一个单位,中风几率增加20.6%(OR = 1.206,P = 0.0144)。限制性立方样条(RCS)分析证实lnPIV和lnSIRI与中风呈J形关联。分层分析确定性别和吸烟为显著的效应修饰因素。吸烟与PIV、SIRI和SII水平升高显著相关,尤其是当前吸烟者。
PIV和SIRI水平升高显著增加高血压个体的中风患病率,在男性和吸烟者中尤为明显。包含PIV、SIRI和社会人口统计学因素的预测模型具有很强的临床实用性。